Envestnet Asset Management’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,696
| Closed | -$16.2K | – | 4207 |
|
|
2023
Q3 | $16.2K | Hold |
2,696
| – | – | ﹤0.01% | 3983 |
|
|
2023
Q2 | $18.6K | Hold |
2,696
| – | – | ﹤0.01% | 3925 |
|
|
2023
Q1 | $42.3K | Hold |
2,696
| – | – | ﹤0.01% | 3864 |
|
|
2022
Q4 | $53.9K | Hold |
2,696
| – | – | ﹤0.01% | 3864 |
|
|
2022
Q3 | $48K | Sell |
2,696
-55
| -2% | -$979 | ﹤0.01% | 3811 |
|
|
2022
Q2 | $61K | Buy |
2,751
+247
| +10% | +$5.48K | ﹤0.01% | 3802 |
|
|
2022
Q1 | $70K | Hold |
2,504
| – | – | ﹤0.01% | 3835 |
|
|
2021
Q4 | $114K | Hold |
2,504
| – | – | ﹤0.01% | 3748 |
|
|
2021
Q3 | $209K | Sell |
2,504
-2,500
| -50% | -$209K | ﹤0.01% | 3488 |
|
|
2021
Q2 | $475K | Hold |
5,004
| – | – | ﹤0.01% | 3024 |
|
|
2021
Q1 | $833K | Buy |
+5,004
| New | +$833K | ﹤0.01% | 2529 |
|